Agammaglobulinemia News and Research

RSS
Researchers analyze targets of human T cell recognition against all coronaviruses

Researchers analyze targets of human T cell recognition against all coronaviruses

COVID-19 outcomes among individuals with common variable immunodeficiency

COVID-19 outcomes among individuals with common variable immunodeficiency

Scientists show how T cells may help protect against severe COVID

Scientists show how T cells may help protect against severe COVID

Improved seroprevalence and antibody response after third COVID-19 vaccination

Improved seroprevalence and antibody response after third COVID-19 vaccination

Key protein could be a novel target for treatment of patients with B cell signaling deficiencies

Key protein could be a novel target for treatment of patients with B cell signaling deficiencies

Convalescent plasma in COVID-19 can be effective, especially early in disease

Convalescent plasma in COVID-19 can be effective, especially early in disease

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

COVID-19 and immunodeficiency

COVID-19 and immunodeficiency

When an insurer balks and treatment stops

When an insurer balks and treatment stops

Researchers find method to repair gene mutation causing autoimmune deficiency disease

Researchers find method to repair gene mutation causing autoimmune deficiency disease

Scientists solve a decades-long mystery of cell biology

Scientists solve a decades-long mystery of cell biology

New insights into how body's innate immunity is triggered to create effective immune response

New insights into how body's innate immunity is triggered to create effective immune response

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

New way to study proteins in live cells

New way to study proteins in live cells

X-linked agammaglobulinemia

X-linked agammaglobulinemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.